Risk of Cancer Following Lumbar Fusion Surgery With Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2): An Analysis Using a Commercially Insured Patient Population
about
Risk of Cancer Following Lumbar Fusion Surgery With Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2): An Analysis Using a Commercially Insured Patient Population
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2018
@uk
name
Risk of Cancer Following Lumba ...... lly Insured Patient Population
@en
Risk of Cancer Following Lumba ...... man Bone Morphogenic Protein-2
@nl
type
label
Risk of Cancer Following Lumba ...... lly Insured Patient Population
@en
Risk of Cancer Following Lumba ...... man Bone Morphogenic Protein-2
@nl
prefLabel
Risk of Cancer Following Lumba ...... lly Insured Patient Population
@en
Risk of Cancer Following Lumba ...... man Bone Morphogenic Protein-2
@nl
P2860
P356
P1476
Risk of Cancer Following Lumba ...... lly Insured Patient Population
@en
P2093
Gregory S Cooper
Tzuyung Doug Kou
P2860
P304
P356
10.14444/50323
P407
P577
2018-04-01T00:00:00Z